XML 80 R57.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Share Capital (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2018
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Abstract] |
Summary of Equity Financing | An unlimited number of common shares.
| (i) | Equity Raises
During fiscal 2018 the Company completed the following equity financings:
|  | Number of Shares |  |  | Share Capital |
Equity financing - February 7, 2018 - net of share issue costs of $8,615 |  |  | 5,800,000 |  |  | $ | 192,065 |
Equity investment from Greenstar - November 2, 2017 - net of share issue costs of $707 |  |  | 18,876,901 |  |  |  | 173,765 |
Equity financing - July 21, 2017 - net of share issue costs of $78 |  |  | 3,105,590 |  |  |  | 24,922 |
Total equity raise share issuances |  |  | 27,782,491 |  |  | $ | 390,752 |
20. | Share capital (CONTINUED)
During fiscal 2017 the Company completed the following equity financings:
|  | Number of Shares |  |  | Share Capital |
Equity private placement financing - March 22, 2017 - net of share issue costs of $90 |  |  | 2,500,000 |  |  | $ | 24,160 |
Equity financing - December 22, 2016 - net of share issue costs of $3,886 |  |  | 5,662,000 |  |  |  | 56,131 |
Equity financing - August 24, 2016 - net of share issue costs of $2,407 |  |  | 9,453,000 |  |  |  | 32,096 |
Equity financing - April 15, 2016 - net of share issue costs of $707 |  |  | 5,002,500 |  |  |  | 10,799 |
Total equity raise share issuances |  |  | 22,617,500 |  |  | $ | 123,186 |
Summary of Equity Issuances Related to Acquisitions |
|  | Notes |  | Number of Shares |  |  | Share Capital |  |  | Share Based Reserve |
Issuance of shares for rTrees acquisition - net of share issue costs of $69 |  | 10(a)(i) |  |  | 3,494,505 |  |  | $ | 28,026 |  |  | $ | 1,079 |
Issuance of shares for Spot acquisition - net of share issue costs of $9 |  | 10(a)(v) |  |  | 111,669 |  |  |  | 984 |  |  |  | - |
Issuance of shares for Green Hemp acquisition - net of share issue costs of $9 |  | 10(a)(v) |  |  | 24,577 |  |  |  | 848 |  |  |  | - |
Shares released from escrow related to the MedCann Access acquisition |  |  |  |  | 240,678 |  |  |  | 390 |  |  |  | (390 | )
Shares released from escrow related to the Hemp.CA acquisition |  | 10(b)(iii) |  |  | 129,016 |  |  |  | - |  |  |  | - |
Shares released from escrow related to the Spektrum Cannabis GmbH acquisition |  | 10(b)(ii) |  |  | 367,981 |  |  |  | - |  |  |  | - |
Shares released from escrow related to the Vert Medical acquisition |  | 10(b)(iii) |  |  | 147,453 |  |  |  | - |  |  |  | - |
Total acquisition related share issuances |  |  |  |  | 4,515,879 |  |  | $ | 30,248 |  |  | $ | 689 |
20. | Share capital (CONTINUED)
During fiscal 2017 the Company issued the following shares as a result of business combinations that occurred in the current or prior years:
|  | Notes |  | Number of Shares |  |  | Share Capital |  |  | Share Based Reserve |
Issuance of shares for Mettrum acquisition - net of share issue costs of $997 |  | 10(b)(i) |  |  | 34,265,042 |  |  | $ | 336,514 |  |  | $ | 12,143 |
Issuance of shares per Spektrum Cannabis GmbH acquisition |  | 10(b)(ii) |  |  | 674,631 |  |  |  | 10,406 |  |  |  | - |
Issuance of shares per Vert acquisition |  | 10(b)(iii) |  |  | 58,978 |  |  |  | 1,664 |  |  |  | - |
Issuance of shares per Hemp acquisition |  | 10(b)(iii) |  |  | 129,021 |  |  |  | 1,711 |  |  |  | - |
Shares released from escrow related to the MedCann Access acquisition |  |  |  |  | 1,011,239 |  |  |  | 2,919 |  |  |  | (468 | )
Total acquisition related share issuances |  |  |  |  | 36,138,911 |  |  | $ | 353,214 |  |  | $ | 11,675 |
Summary of Other Equity Issuances | During fiscal 2018 the Company other share issuances were comprised of:
|  | Notes |  | Number of Shares |  |  | Share Capital |  |  | Share Based Reserve |
Shares released from escrow to LBC Holdings, Inc. |  |  |  |  | 87,836 |  |  | $ | 1,297 |  |  | $ | (1,297 | )
Shares issued to BC Tweed Partner for performance conditions |  | 20(c) |  |  | 155,158 |  |  |  | 1,880 |  |  |  | (1,880 | )
Shares issued for Apollo/Bodystream earnout |  | 20(c) |  |  | 243,493 |  |  |  | 2,398 |  |  |  | (2,398 | )
Issuance of shares for Niagara asset acquisition - net of share issue costs of $8 |  | 9 |  |  | 111,366 |  |  |  | 995 |  |  |  | - |
Issuance of shares for acquired intangible - net of share issue costs of $14 |  | 11 |  |  | 117,253 |  |  |  | 3,225 |  |  |  | - |
Total other share issuances |  |  |  |  | 715,106 |  |  | $ | 9,795 |  |  | $ | (5,575 | )
During fiscal 2017 the Company other share issuances were comprised of:
|  |  |  | Number of Shares |  |  | Share Capital |  |  | Share Based Reserve |
Shares released from escrow to LBC Holdings, Inc. |  |  |  |  | 138,032 |  |  | $ | 639 |  |  | $ | (639 | )
Issuance of shares for 1 Hershey Drive purchase |  | 9 |  |  | 94,397 |  |  |  | 858 |  |  |  | - |
Issuance of shares per service agreements |  |  |  |  | 156,240 |  |  |  | 1,333 |  |  |  | - |
Total other share issuances |  |  |  |  | 388,669 |  |  | $ | 2,830 |  |  | $ | (639 | )
Summary of Warrants |
| (i) | Warrants
|  | Number of whole warrants |  |  | Average exercise price |  |  | Warrant value |  |  | Expiry date
Balance at March 31, 2017 |  |  | - |  |  | $ | - |  |  | $ | - |  |  |
Greenstar equity investment - net of warrant issue cost of $253 |  |  | 18,876,901 |  |  |  | 12.98 |  |  |  | 70,265 |  |  | May 1, 2020
rTrees acquisition |  |  | 242,408 |  |  |  | 3.83 |  |  |  | 1,302 |  |  | April 30, 2018
Exercise of warrants |  |  | (207,297 | ) |  |  | 3.72 |  |  |  | (1,113 | ) |  | N/A
Balance at March 31, 2018 |  |  | 18,912,012 |  |  | $ | 12.96 |  |  | $ | 70,454 |  |  |
Summary of Changes in ESOP Options |
20. | Share capital (CONTINUED)
The following is a summary of the changes in the Company’s ESOP options during the period:
| Options issued |  |  | Weighted average exercise price |
Balance outstanding at March 31, 2016 |  | 8,446,182 |  |  | $ | 2.05 |
Options granted |  | 4,337,701 |  |  |  | 6.23 |
Replacement options issued as a result of the Mettrum acquisition |  | 2,417,102 |  |  |  | 2.35 |
Options exercised |  | (4,010,865 | ) |  |  | 1.74 |
Options forfeited/cancelled |  | (1,146,008 | ) |  |  | 2.78 |
Balance outstanding at March 31, 2017 |  | 10,044,112 |  |  | $ | 3.97 |
Options granted |  | 12,832,237 |  |  |  | 16.50 |
Replacement options issued as a result of the rTrees acquisition |  | 224,433 |  |  |  | 3.18 |
Options exercised |  | (3,912,946 | ) |  |  | 2.82 |
Options forfeited/cancelled |  | (1,942,001 | ) |  |  | 9.32 |
Balance outstanding at March 31, 2018 |  | 17,245,835 |  |  | $ | 12.95 |
Summary of Outstanding Stock Options | The following is a summary of the outstanding stock options as at March 31, 2018:
Options Outstanding | Options Exercisable
Number Outstanding at March 31, 2018 |  | Weighted Average Remaining Contractual Life (years) |  | Range of Exercise Prices | Number Exercisable at March 31, 2018 |  | Range of Exercise Prices
| 3,471,904 |  |  | 3.41 |  | $0.56 - $3.78 |  | 1,569,274 |  | $0.56 - $3.78
| 5,731,691 |  |  | 5.13 |  | $3.79 - $8.51 |  | 577,665 |  | $3.79 - $8.51
| 2,712,240 |  |  | 4.91 |  | $8.52 - $11.76 |  | 536,254 |  | $8.52 - $11.76
| 1,540,000 |  |  | 5.67 |  | $11.77 - $27.94 |  | 16,667 |  | $11.77 - $27.94
| 3,790,000 |  |  | 5.88 |  | $27.95 - $33.66 |  | - |  | $27.95 - $33.66
| 17,245,835 |  |  | 4.96 |  |  |  | 2,699,860 |  |
Summary of Assumptions Used Following Black-Scholes Option Pricing Model to Establish Fair Value of Options |
20. | Share capital (CONTINUED)
In determining the amount of share-based compensation related to options issued during the year, the Company used the Black-Scholes option pricing model to establish the fair value of options granted during the year ended March 31, 2018 and 2017 on their measurement date by applying the following assumptions:
| March 31, |  |  | March 31, |
| 2018 |  |  | 2017 |
| (Weighted average) |  |  | (Range) |
Risk-free interest rate | 1.54% |  |  | 0.50% - 1.94% |
Expected life of options (years) | 3 - 5 |  |  | 1 - 6 |
Expected annualized volatility | 64% |  |  | 55% - 70% |
Expected forfeiture rate | 11% |  |  | 7% |
Expected dividend yield | nil |  |  | nil |
Black-Scholes value of each option | $ | 8.88 |  |  | $0.20 - $6.09 |
Summary of Share-based Compensation Expense related to Acquisition | Share-based compensation expense related to acquisition milestones is comprised of:
|  |  |  |  |  |  |  | Compensation expense |
| Notes | Released during fiscal 2018 |  | Remaining shares to be issued on completion of milestones* |  | March 31, 2018 |  |  | March 31, 2017 |
Apollo/Bodystream | (i) |  | 243,493 |  |  | 1,941,804 |  | $ | 5,095 |  |  | $ | 690 |
Spektrum Cannabis GmBH | (ii) |  | - |  |  | 23,570 |  |  | 349 |  |  |  | - |
Spot | 10(a)(v) |  | - |  |  | 30,658 |  |  | 330 |  |  |  | - |
Spectrum Denmark | 10(a)(iii) |  | - |  |  | 1,906,214 |  |  | 7,206 |  |  |  | - |
BC Tweed | 13 |  | 155,158 |  |  | 240,061 |  |  | 5,001 |  |  |  | - |
Vert Mirabel | 10(a)(iv) |  | - |  |  | 84,903 |  |  | 1,131 |  |  |  | - |
Green Hemp | 10(a)(v) |  | - |  |  | 24,567 |  |  | 167 |  |  |  | - |
Intellectual property acquisition | 11 |  | - |  |  | 33,804 |  |  | 196 |  |  |  | - |
|  |  |  |  |  |  |  | $ | 19,475 |  |  | $ | 690 |
20. | Share capital (CONTINUED)
| (i) | The obligation for share-based compensation owing to former shareholders of Apollo Applied Research Inc., and Apollo CRO Inc. (together “Apollo”) and 2344823 Ontario Inc., operating as Bodystream (“Bodystream”) was assumed by the Company in fiscal 2017 on the acquisition of Mettrum Health Corp. and its subsidiaries (“Mettrum”). The maximum number of Company shares that would be issued with respect to the Apollo and Bodystream agreements is 1,111,702 and 1,073,595 shares, respectively. The Company has estimated the number of shares it expects to vest and is amortizing the expense over the expected vesting period based on the fair value of the shares on the acquisition date.
| (ii) | The share-based compensation expense is related to a bonus that will be paid to a former shareholder of Spektrum Cannabis GmbH within two years of the acquisition date if certain performance targets are met and the shareholder remains as an employee.

X
- Definition Disclosure of individual equity financing and private placements which reconcile to amounts disclosed in the Statement of Shareholder's Equity. + References No definition available. + Details
Name: | cgc_DisclosureOfEquityFinancingAndPrivatePlacementExplanatory
Namespace Prefix: | cgc_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of individual equity issuances that relate to acquisition transactions. + References No definition available. + Details
Name: | cgc_DisclosureOfEquityIssuancesRelatedToAcquisitionsExplanatory
Namespace Prefix: | cgc_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of individual other share issuance transactions. + References No definition available. + Details
Name: | cgc_DisclosureOfOtherEquityIssuancesExplanatory
Namespace Prefix: | cgc_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share based compensation expense related to acquisition. + References No definition available. + Details
Name: | cgc_DisclosureOfShareBasedCompensationExpenseRelatedToAcquisitionExplanatory
Namespace Prefix: | cgc_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of warrant explanatory. + References No definition available. + Details
Name: | cgc_DisclosureOfWarrantExplanatory
Namespace Prefix: | cgc_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2017-01-01 -Paragraph 47 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=2&date=2017-03-01&anchor=para_47_a&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2017-01-01 -Paragraph 45 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=2&date=2017-03-01&anchor=para_45_b&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2017-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=2&date=2017-03-01&anchor=para_45_d&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration